Insider Buying: Mobia Medical (NASDAQ:MOBI) CFO Acquires $63,950.00 in Stock

Mobia Medical, Inc. (NASDAQ:MOBI) CFO Nelson Bunker Curnes acquired 5,000 shares of Mobia Medical stock in a transaction on Tuesday, June 9th. The stock was purchased at an average cost of $12.79 per share, for a total transaction of $63,950.00. Following the purchase, the chief financial officer owned 366,997 shares in the company, valued at approximately $4,693,891.63. The trade was a 1.38% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Mobia Medical Stock Performance

NASDAQ:MOBI opened at $12.31 on Friday. Mobia Medical, Inc. has a 1 year low of $10.19 and a 1 year high of $14.77. The company has a market capitalization of $409.30 million, a price-to-earnings ratio of 66.00 and a beta of 2.84.

Mobia Medical (NASDAQ:MOBI) last released its quarterly earnings data on Thursday, June 4th. The company reported $999.00 earnings per share (EPS) for the quarter. The firm had revenue of $12.07 million during the quarter.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. BTIG Research assumed coverage on Mobia Medical in a report on Tuesday, June 2nd. They issued a “buy” rating and a $19.00 target price for the company. Zacks Research upgraded Mobia Medical to a “hold” rating in a report on Wednesday, June 3rd. Wolfe Research assumed coverage on Mobia Medical in a report on Tuesday, June 2nd. They issued an “outperform” rating for the company. Bank of America assumed coverage on Mobia Medical in a report on Tuesday, June 2nd. They issued a “buy” rating and a $16.00 target price for the company. Finally, JPMorgan Chase & Co. assumed coverage on Mobia Medical in a report on Tuesday, June 2nd. They issued an “overweight” rating and a $15.00 target price for the company. Five equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, Mobia Medical currently has a consensus rating of “Moderate Buy” and a consensus target price of $20.25.